| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303365A Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 07/11/2001 | CN1303295A Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 07/11/2001 | CN1302883A Polypeptide-human enameling protein 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302662A Oral immune using plant product containing non entero pathogene antigen |
| 07/11/2001 | CN1302653A Medicinal composition containing aloe and its application |
| 07/11/2001 | CN1302651A Oral immune using plant product containing hepatitis surface antigen |
| 07/11/2001 | CN1302648A Powdered medicine for treating gastroenteritis and its preparing process |
| 07/11/2001 | CN1302647A Medical capsule for treating hepatitis and its preparing process |
| 07/11/2001 | CN1302645A Medical capsule for invigorating function of spleen and its preparing process |
| 07/11/2001 | CN1302642A Chinese medicine for treating tuberculosis and hepatitis |
| 07/11/2001 | CN1302632A Medical capsule for invigorating function of stomach and intestine and its preparing process |
| 07/11/2001 | CN1302623A Chinese patent medicine for treating gastrosis and its preparing process |
| 07/11/2001 | CN1302616A Powdered medicine for treating simple baby diarrhea |
| 07/11/2001 | CN1302614A Medicine for treating baby diarrhea |
| 07/11/2001 | CN1302612A Preparation method of medicinal composition containing 1,3-oxathin cyclopentane nucleoside analogues |
| 07/11/2001 | CN1302559A Curcumin preparation |
| 07/11/2001 | CN1068327C 2,7-Substituted octahydro-1H-pyrido [1,2-alpha]pyrazin derivatives |
| 07/11/2001 | CN1068318C 2-Substituted 1,2,5-thiadiazolidin-3-onel, 1-dioxides and compositions and method of use thereof |
| 07/11/2001 | CN1068314C Triazole compounds and their use as dopamine -D3-ligands |
| 07/10/2001 | US6258953 Arylacrylamide derivatives |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258817 Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof |
| 07/10/2001 | US6258800 Prodrugs of benzofuranylethyl carbamate NK1 antagonists |
| 07/10/2001 | US6258790 Antisense modulation of integrin α4 expression |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258376 Treating helicobacter infections and gastrointestinal disorders; antiulcer agents |
| 07/10/2001 | CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition |
| 07/10/2001 | CA2139653C Optically pure salts of pyridinylmethyl sulfinyl-ih- benzimidazole compounds |
| 07/10/2001 | CA2017135C Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments |
| 07/05/2001 | WO2001048203A1 Novel protein and dna thereof |
| 07/05/2001 | WO2001048153A1 Reconstructing organs from decellularized biomaterial scaffold |
| 07/05/2001 | WO2001048020A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | WO2001047961A1 P. gingivalis antigenic composition |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047922A2 Azaindoles |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047920A1 Benzazole derivatives and their use as jnk modulators |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047904A1 Thiazolyl amide derivatives |
| 07/05/2001 | WO2001047901A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/05/2001 | WO2001047897A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047887A1 β-AMINO ACID COMPOUNDS AS INTEGRIN ANTAGONISTS |
| 07/05/2001 | WO2001047885A1 Substituted indole mannich bases |
| 07/05/2001 | WO2001047883A1 Fused-ring compounds and use thereof as drugs |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047879A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | WO2001047878A1 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 07/05/2001 | WO2001047874A1 (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| 07/05/2001 | WO2001047866A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | WO2001047545A1 Preventives and remedies for chronic hepatitis |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | WO2001010392A3 Composition for restoring defects in calcified tissues |
| 07/05/2001 | WO2001003720A9 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2000078745A3 Crystalline form of (r)-2-[[[3-methyl- 4- (2,2,2,- trifluoroethoxy) -2- pyridinyl] methyl] sulfinyl] -1h-benzimidazole |
| 07/05/2001 | WO2000073278A3 5-phenyl-pyrimidine derivatives |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000052134A3 Inhibitors of prenyl-protein transferase |
| 07/05/2001 | WO2000040247A8 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 07/05/2001 | WO2000023114A9 Polymer conjugates of interferon beta- 1a and their uses |
| 07/05/2001 | WO2000018799A9 Artemin, a novel neurotrophic factor |
| 07/05/2001 | US20010006973 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 07/05/2001 | US20010006971 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-HT7 receptors |
| 07/05/2001 | US20010006957 Microdispersed or microfibrillar polyanhydroglucuronic acids and salts, complex salts or intermolecular polymer complexes suitable for fixing drug dosages with significantly protracted effect and reduced toxicity |
| 07/05/2001 | US20010006940 Human chorionic gonadotrophin (hCG) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |
| 07/05/2001 | US20010006939 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 07/05/2001 | US20010006674 Mixture for use as wound dressing |
| 07/05/2001 | US20010006649 Stable oral pharmaceutical dosage forms |
| 07/05/2001 | DE19963178A1 Substituierte Indol-Mannichbasen Substituted indole Mannich bases |
| 07/05/2001 | CA2699568A1 Azaindoles |
| 07/05/2001 | CA2396693A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2396502A1 Substituted pyrrole mannich bases |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395423A1 P. gingivalis antigenic composition |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2395242A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395173A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | CA2394727A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | CA2394098A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | CA2392866A1 Substituted indole mannich bases |
| 07/05/2001 | CA2363274A1 Fused-ring compounds and use thereof as drugs for hepatitis c |
| 07/04/2001 | EP1113015A1 Optically active 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluoromethyl)-phenyl)-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists |
| 07/04/2001 | EP1112750A1 Drug composition for topical administration |
| 07/04/2001 | EP1112692A1 Drinks and foods capable of eliminating i helicobacter pylori /i |
| 07/04/2001 | EP1112364A2 Stomach polypeptide zsig28 |
| 07/04/2001 | EP1112285A1 Human chordin-related proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112266A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 07/04/2001 | EP1112265A1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |